Strand Therapeutics
Strand Therapeutics is a Biotechnology Research company. strand is a clinical-stage biotechnology company that develops breakthrough mRNA therapeutics for cancers and autoimmune diseases. They aim to solve the biggest problems in genetic medicine by building plug-and-play delivery systems that bring therapies to vastly more patients and indications. Strand Therapeutics employs 124 people (+14.8% YoY, +16 people) and has an annual revenue of $2.3M, founded in 2017. Headquartered in Boston, Massachusetts, United States, with an office in
Showing a preview — retrieve the full document via the Exa API.
Powered by the Exa API